"Koivunen, Jussi P." - Selaus tekijän mukaan TUNICRIS-julkaisut
Viitteet 1-4 / 4
-
Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors: The phase I/II first-in-human MATINS trial
(19.12.2023)
articleMacrophage Clever-1 contributes to impaired antigen presentation and suppression of anti-tumor immunity. This first-in-human trial investigates the safety and tolerability of Clever-1 blockade with bexmarilimab in patients ... -
Lung cancer screening in Finland: a prospective randomized trial
(2025)
articleBACKGROUND: Early detection of lung cancer with low-dose computed tomography (LDCT) screening can shift diagnoses to early-stage disease and improve survival. However, LDCT has several challenges such as high false positive ... -
The prognostic and predictive roles of plasma C-reactive protein and PD-L1 in non-small cell lung cancer
(2023)
article<p>Background: Anti-PD-(L)1 agents have revolutionized the treatment paradigms of non-small cell lung cancer (NSCLC), while predictive biomarkers are limited. It has been previously shown that systemic inflammation, ... -
Smartphone application versus written material for smoking reduction and cessation in individuals undergoing low-dose computed tomography (LDCT) screening for lung cancer: a phase II open-label randomised controlled trial
(07 / 2024)
articleBackground: Counseling, nicotine replacement, and other cessation medications have been proven effective in smoking cessation. The wide-scale adoption of smartphones and other mobile devices has opened new possibilities ...
